California State Teachers Retirement System increased its stake in Avantor, Inc. (NYSE:AVTR – Free Report) by 22.6% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 785,799 shares of the company’s stock after acquiring an additional 145,045 shares during the quarter. California State Teachers Retirement System’s holdings in Avantor were worth $6,161,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada lifted its position in shares of Avantor by 104.3% in the 1st quarter. Royal Bank of Canada now owns 203,738 shares of the company’s stock worth $3,302,000 after purchasing an additional 104,022 shares during the period. Empowered Funds LLC increased its position in shares of Avantor by 40.3% during the first quarter. Empowered Funds LLC now owns 17,659 shares of the company’s stock worth $286,000 after buying an additional 5,075 shares during the period. Cetera Investment Advisers raised its stake in Avantor by 40.2% during the second quarter. Cetera Investment Advisers now owns 40,289 shares of the company’s stock worth $542,000 after buying an additional 11,543 shares during the last quarter. Quantbot Technologies LP bought a new position in Avantor during the second quarter worth $232,000. Finally, Arrowstreet Capital Limited Partnership lifted its holdings in Avantor by 214.9% in the second quarter. Arrowstreet Capital Limited Partnership now owns 124,076 shares of the company’s stock valued at $1,670,000 after buying an additional 84,679 shares during the period. 95.08% of the stock is currently owned by institutional investors.
Avantor Price Performance
AVTR stock opened at $13.38 on Thursday. The company has a debt-to-equity ratio of 0.65, a quick ratio of 1.18 and a current ratio of 1.78. The business has a 50-day simple moving average of $10.58 and a two-hundred day simple moving average of $9.46. The company has a market capitalization of $9.05 billion, a P/E ratio of -15.92, a price-to-earnings-growth ratio of 10.30 and a beta of 0.89. Avantor, Inc. has a 52-week low of $7.26 and a 52-week high of $15.93.
Wall Street Analysts Forecast Growth
A number of analysts have commented on the stock. UBS Group set a $8.00 price target on shares of Avantor in a research report on Wednesday, June 24th. Wolfe Research raised Avantor from a “strong sell” rating to a “hold” rating in a research note on Thursday, July 30th. Jefferies Financial Group upgraded Avantor from an “underperform” rating to a “hold” rating and set a $13.00 target price on the stock in a research report on Wednesday, July 29th. Citigroup raised their target price on Avantor from $9.00 to $11.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 8th. Finally, Morgan Stanley lifted their target price on Avantor from $10.00 to $14.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Two investment analysts have rated the stock with a Buy rating, fifteen have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, Avantor presently has an average rating of “Hold” and a consensus target price of $12.00.
Check Out Our Latest Stock Analysis on Avantor
Insider Transactions at Avantor
In related news, Director Gregory T. Lucier purchased 10,000 shares of the firm’s stock in a transaction that occurred on Friday, May 8th. The stock was acquired at an average price of $8.32 per share, for a total transaction of $83,200.00. Following the completion of the acquisition, the director owned 60,000 shares of the company’s stock, valued at $499,200. This represents a 20.00% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 0.28% of the company’s stock.
Avantor Profile
Avantor, Inc (NYSE:AVTR) is a global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company delivers essential solutions that support research, development, production and safety applications. Its product portfolio spans from high-purity chemicals and reagents to biologics and cell culture media, as well as lab equipment, consumables and custom manufacturing services.
Avantor’s offerings are organized across two primary segments.
Further Reading
- Five stocks we like better than Avantor
- SpaceX: Love the Company, But the Stock Is a Harder Call
- Ulta’s Growth Is Real, But So Are the Risks
- BWX Technologies Is Turning the AI Power Problem Into a Nuclear Growth Story
- Meta’s Earnings Drop Shows Wall Street Wants More Than Ad Growth
Want to see what other hedge funds are holding AVTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Avantor, Inc. (NYSE:AVTR – Free Report).
Receive News & Ratings for Avantor Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avantor and related companies with MarketBeat.com's FREE daily email newsletter.
